Patent 5470885 Issued on November 28, 1995. Estimated Expiration Date: September 29, 2013. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
514/743, Halogenated hydrocarbon DOAI128/204.18, Means for supplying respiratory gas under positive pressure514/759, Fluorine as only halogen514/848, Facial astringent514/886, INFLAMMATION, SKIN514/887, Topical Treatment514/959BREATHING GASES
A method for reducing the inflammatory response in tissue of a patient, by contacting the tissue with an effective, inflammation-reducing amount of a liquid or gaseous fluorocarbon.
Other References
Calderwood, et al., "Residual Levels and Biochemical Changes after Ventilation with Perfluorinated Liquid", J. Appl. Physiol., 34:4, pp. 603-607, 1975
Forman, et al., "A Fine Structure Study of the Liquid-Ventilated Newborn Rabbit Lung", Federation Proc. 43:647, Abstract 2118
Modell, et al., "Liquid Ventilation of Primates", Chest 69: pp. 79-81, 1976
Modell, et al., "Long-Term Survival of Dogs after Breathing Oxygenated Fluorocarbon Liquid", Federation Proceedings 29:5 pp. 1731-1739, 1970
Jean G. Riess, "Reassessment of Criteria for the Selection of Perfluorochemicals for Second-Generation Blood Substitutes: Analysis of Structure/Property Relationships", Artificial Organs 8:1 pp. 44-56, 1984
Hirschl, et al., The FASEB Journal 7(3): p. A229, 199